, Volume 236, Issue 1, pp 517–529 | Cite as

Effects of a histone deacetylase 3 inhibitor on extinction and reinstatement of cocaine self-administration in rats

  • Leah N. Hitchcock
  • Jonathan D. Raybuck
  • Marcelo A. Wood
  • K. Matthew LattalEmail author
Original Investigation



A challenge in treating substance use disorder is that successful treatment often does not persist, resulting in relapse and continued drug seeking. One approach to persistently weaken drug-seeking behaviors is to pair exposure to drug-associated cues or behaviors with delivery of a compound that may strengthen the inhibition of the association between drug cues and behavior.


We evaluated whether a selective histone deacetylase 3 (HDAC3) inhibitor could promote extinction and weaken contextual control of operant drug seeking after intravenous cocaine self-administration.


Male Long-Evans rats received a systemic injection of the HDAC3 inhibitor RGFP966 either before or immediately after the first extinction session. Persistence of extinction was tested over subsequent extinction sessions, as well as tests of reinstatement that included cue-induced reinstatement, contextual renewal, and cocaine-primed reinstatement. Additional extinction sessions occurred between each reinstatement test. We also evaluated effects of RGFP966 on performance and motivation during stable fixed ratio operant responding for cocaine and during a progressive ratio of reinforcement.


RGFP966 administered before the first extinction session led to significantly less responding during subsequent extinction and reinstatement tests compared to vehicle-injected rats. Follow-up studies found that these effects were not likely due to a performance deficit or a change in motivation to self-administer cocaine, as injections of RGFP966 had no effect on stable responding during a fixed or progressive ratio schedule. In addition, RGFP966 administered just after the first extinction session had no effect during early extinction and reinstatement tests, but weakened long-term responding during later extinction sessions.


These results suggest that a systemic injection of a selective HDAC3 inhibitor can enhance extinction and suppress reinstatement after cocaine self-administration. The finding that behavioral and pharmacological manipulations can be combined to decrease drug seeking provides further potential for treatment by epigenetic modulation.


Histone acetylation Epigenetics Intravenous cocaine Extinction Long-Evans rats 


Funding information

Financial support was provided by the National Institute on Drug Abuse (NIDA) grants P50DA018165 (KML), R01DA025922 (KML and MAW) and R01DA025922S1 (KML and MAW), and T32DA007262 (LNH); the Department of Defense grant W81XWH-12-2-0048 (KML); and the American Psychological Association APA 1006636 (LNH).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Alaghband Y, Kwapis JL, López AJ, White AO, Aimiuwu OV, Al-Kachak A et al (2017) Distinct roles for the deacetylase domain of HDAC3 in the hippocampus and medial prefrontal cortex in the formation and extinction of memory. Neurobiol Learn Mem 145:94–104. CrossRefPubMedPubMedCentralGoogle Scholar
  2. Andersen CL, Mcmullin MF, Ejerblad E, Zweegman S, Harrison C, Fernandes S et al (2013) A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia. Br J Haematol 162(4):498–508. CrossRefPubMedGoogle Scholar
  3. Arrar M, de Oliveira CAF, McCammon JA (2013) Inactivating mutation in histone deacetylase 3 stabilizes its active conformation. Protein Sci 22(10):1306–1312. CrossRefPubMedPubMedCentralGoogle Scholar
  4. Berglind WJ, See RE, Fuchs RA, Ghee SM, Whitfield TW, Miller SW, McGinty JF (2007) A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci 26:757–766. CrossRefPubMedGoogle Scholar
  5. Bieszczad KM, Bechay K, Rusche JR, Jacques V, Kudugunti S, Miao W, Weinberger NM, McGaugh JL, Wood MA (2015) Histone deacetylase inhibition via RGFP966 releases the brakes on sensory cortical plasticity and the specificity of memory formation. J Neurosci 35(38):13124–13132. CrossRefPubMedPubMedCentralGoogle Scholar
  6. Blank M, Dornelles AS, Werenicz A, Velho LA, Pinto DF, Fedi AC, Schröder N, Roesler R (2014) Basolateral amygdala activity is required for enhancement of memory consolidation produced by histone deacetylase inhibition in the hippocampus. Neurobiol Learn Mem 111(1–8):1–8. CrossRefPubMedGoogle Scholar
  7. Bossert JM, Marchant NJ, Calu DJ, Shaham Y (2013) The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology 229:453–476. CrossRefPubMedPubMedCentralGoogle Scholar
  8. Bongiovanni M, See RE (2008) A comparison of the effects of different operant training experiences and dietary restriction on the reinstatement of cocaine-seeking in rats. Pharmacol Biochem Behav 89(2):227–233.Google Scholar
  9. Bousiges O, Neidl R, Majchrzak M, Muller MA, Barbelivien A, Pereira de Vasconcelos A, Schneider A, Loeffler JP, Cassel JC, Boutillier AL (2013) Detection of histone acetylation levels in the dorsal hippocampus reveals early tagging on specific residues of H2B and H4 histones in response to learning. PLoS One 8(3):e57816. CrossRefPubMedPubMedCentralGoogle Scholar
  10. Bouton ME, Todd TP (2014) A fundamental role for context in instrumental learning and extinction. Behav Process 104:13–19CrossRefGoogle Scholar
  11. Bowers ME, Xia B, Carreiro S, Ressler KJ (2015) The Class I HDAC inhibitor RGFP963 enhances consolidation of cued fear extinction. Learn Mem 22(4):225–231. CrossRefPubMedPubMedCentralGoogle Scholar
  12. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M (2007) Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. 14:268–276.
  13. Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ (2007) Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci 31:47–58. CrossRefPubMedGoogle Scholar
  14. Castino MR, Cornish JL, Clemens KJ, Wittnam J, Held T, Bahr M (2015) Inhibition of histone deacetylases facilitates extinction and attenuates reinstatement of nicotine self-administration in rats. PLoS One 10(4):e0124796. CrossRefPubMedPubMedCentralGoogle Scholar
  15. Crombag HS, Shaham Y (2002) Renewal of drug seeking by contextual cues after prolonged extinction in rats. Behav Neurosci 116(1):169–173. CrossRefGoogle Scholar
  16. Crombag HS, Grimm JW, Shaham Y (2002) Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues. Neuropsychopharmacology 27(6):1006–1015. CrossRefPubMedGoogle Scholar
  17. Dagnas M, Micheau J, Decorte L, Beracochea D, Mons N (2015) Post-training, intrahippocampal HDAC inhibition differentially impacts neural circuits underlying spatial memory in adult and aged mice. Hippocampus 25(7):827–837. CrossRefPubMedGoogle Scholar
  18. Depoortere RY, Li DH, Lane JD, Emmett-Oglesby MW (1993) Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacol Biochem Behav 45(3):539–548CrossRefGoogle Scholar
  19. Dokmanovic M, Clarke C, Marks PA (2007) Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5:981–989. CrossRefPubMedGoogle Scholar
  20. Farrell M R, Schoch H, Mahler SV (2018) Modeling cocaine relapse in rodents: Behavioral considerations and circuit mechanisms. Prog Neuro-Psychopharmacol Biol PsychiatryGoogle Scholar
  21. Foley AG, Cassidy AW, Regan CM (2014) Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders. Eur J Pharmacol 727:80–86. CrossRefPubMedGoogle Scholar
  22. Fuchs RA, Tran-Nguyen LTL, Specio SE, Groff RS, Neisewander JL (1998) Predictive validity of the extinction/reinstatement model of drug craving. Psychopharmacology 135(2):151–160. CrossRefGoogle Scholar
  23. Fuchs RA, Evans KA, Ledford CC, Parker MP, Case JM, Mehta RH, See RE (2005) The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 30(2):296–309. CrossRefPubMedGoogle Scholar
  24. Gabriele A, Pacchioni AM, See RE (2012) Dopamine and glutamate release in the dorsolateral caudate putamen following withdrawal from cocaine self-administration in rats. Pharmacol Biochem Behav 103(2):373–379. CrossRefPubMedPubMedCentralGoogle Scholar
  25. Gaglio D, Capitano F, Mastrodonato A, Minicocci E, Deiana C, Fragapane P, Camilloni G, Mele A (2014) Learning induced epigenetic modifications in the ventral striatum are necessary for long-term memory. Behav Brain Res 265:61–68. CrossRefPubMedGoogle Scholar
  26. Guan J-S, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJF, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai L-H (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459(7243):55–60. CrossRefPubMedPubMedCentralGoogle Scholar
  27. Gulick D, Gould TJ (2007) Acute ethanol has biphasic effects on short‐and long‐term memory in both foreground and background contextual fear conditioning in C57BL/6 mice. Alcoholism: Clinical and Experimental Research, 31(9): 1528–1537.Google Scholar
  28. Hitchcock LN, Lattal KM (2014) Histone-mediated epigenetics in addiction. In: Akbarian S, Lubin F (eds) Progress in Molecular Biology and translational Science. Epigenetics and Neuroplasticity - Evidence and Debate, vol 128, 128th edn. Elsevier Inc, pp 51–87.
  29. Hitchcock LN, Lattal KM (2018) Involvement of the dorsal hippocampus in expression and extinction of cocaine-induced conditioned place preference. Hippocampus 28(3):226–238CrossRefGoogle Scholar
  30. Hitchcock LN, Cunningham CL, Lattal KM (2014) Cue configuration effects in acquisition and extinction of a cocaine-induced place preference. Behav Neurosci 128(2):217–227CrossRefGoogle Scholar
  31. Jeanblanc J, Lemoine S, Jeanblanc V, Alaux-Cantin SS, Naassila MM (2015) The class I-specific HDAC inhibitor MS-275 decreases motivation to consume alcohol and relapse in heavy drinking rats. Int J Neuropsychopharmacol 18:1–9. CrossRefGoogle Scholar
  32. Kennedy PJ, Harvey E (2015) Histone deacetylases as potential targets for cocaine addiction. CNS Neurol Disord Drug Targets 14(6):764–772CrossRefGoogle Scholar
  33. Kiefer F, Dinter C (2013) New approaches to addiction treatment based on learning and memory. Curr Top Behav Neurosci 13:671–684. CrossRefPubMedGoogle Scholar
  34. Kouzarides T (2007) Chromatin modifications and their function. Cell 128(4):693–705. CrossRefPubMedPubMedCentralGoogle Scholar
  35. Kuntz-Melcavage KL, Brucklacher RM, Grigson PS, Freeman WM, Vrana KE (2009) Gene expression changes following extinction testing in a heroin behavioral incubation model. BMC Neurosci 10:95. CrossRefPubMedPubMedCentralGoogle Scholar
  36. Lattal KM, Barrett RM, Wood MA (2007) Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci 121(5):1125–1131. CrossRefPubMedGoogle Scholar
  37. Liu XF, Bagchi MK (2004) Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J Biol Chem 279(15):15050–15058. CrossRefPubMedGoogle Scholar
  38. Lopez-Atalaya JP, Ito S, Valor LM, Benito E, Barco A (2013) Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition. Nucleic Acids Res 41(17):8072–8084. CrossRefPubMedPubMedCentralGoogle Scholar
  39. Malvaez M, Sanchis-Segura C, Vo D, Lattal KM, Wood MA (2010) Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry 67(1):36–43. CrossRefPubMedPubMedCentralGoogle Scholar
  40. Malvaez M, McQuown SC, Rogge GA, Astarabadi M, Jacques V, Carreiro S et al (2013) HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc Natl Acad Sci 110(7):2647–2652. CrossRefPubMedGoogle Scholar
  41. Malvaez M, Greenfield VY, Matheos DP, Angelillis NA, Murphy MD, Kennedy PJ, Wood MA, Wassum KM (2018) Habits are negatively regulated by histone deacetylase 3 in the dorsal striatum. Biol Psychiatry 84:383–392CrossRefGoogle Scholar
  42. Maze I, Noh K-M, Allis CD (2012) Histone regulation in the CNS: basic principles of epigenetic plasticity. Neuropsychopharmacology 38(1):3–22. CrossRefPubMedPubMedCentralGoogle Scholar
  43. McQuown SC, Wood MA (2011) HDAC3 and the molecular brake pad hypothesis. Neurobiol Learn Mem 96(1):27–34. CrossRefPubMedPubMedCentralGoogle Scholar
  44. McQuown SC, Barrett RM, Matheos DP, Post RJ, Rogge GA, Alenghat T et al (2011) HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci 31(2):764–774. CrossRefPubMedPubMedCentralGoogle Scholar
  45. Millan EZ, Marchant NJ, McNally GP (2011) Extinction of drug seeking. Behav Brain Res 217(2): 454–462.Google Scholar
  46. Morrison FG, Ressler KJ (2014) From the neurobiology of extinction to improved clinical treatments. Depress Anxiety 31(4):279–290. CrossRefPubMedGoogle Scholar
  47. Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LTL, Palmer A, Marshall JF (2000) Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 20(2):798–805. CrossRefGoogle Scholar
  48. Nott A, Cheng J, Gao F, Lin YT, Gjoneska E, Ko T et al (2016) Histone deacetylase 3 associates with MeCP2 to regulate FOXO and social behavior. Nat Neurosci 19(11):1497–1505. CrossRefPubMedPubMedCentralGoogle Scholar
  49. Penney J, Tsai L-H (2014) Histone deacetylases in memory and cognition. Sci Signal 7(355):re12. CrossRefPubMedGoogle Scholar
  50. Phan ML, Gergues MM, Mahidadia S, Jimenez-Castillo J, Vicario DS, Bieszczad KM (2017) Hdac3 inhibitor Rgfp966 modulates neuronal memory for vocal communication signals in a songbird model. Front Syst Neurosci 11:65CrossRefGoogle Scholar
  51. Pizzimenti CL, Lattal KM (2015) Epigenetics and memory: causes, consequences and treatments for post‐traumatic stress disorder and addiction. Genes, Brain and Behavior, 14(1):73–84.Google Scholar
  52. Pizzimenti CL, Navis TM, Lattal K M (2017) Persistent effects of acute stress on fear and drugseeking in a novel model of the comorbidity between post-traumatic stress disorder and addiction. Learning & Memory, 24(9):422–431.Google Scholar
  53. Ploense KL, Kerstetter KA, Wade MA, Woodward NC, Maliniak D, Reyes M, Kippin TE (2013) Exposure to histone deacetylase inhibitors during Pavlovian conditioning enhances subsequent cue-induced reinstatement of operant behavior. Behav. Pharmacol. 24(3):164-171Google Scholar
  54. Rai M, Soragni E, Chou CJ, Barnes G, Jones S, Rusche JR, Gottesfeld JM, Pandolfo M (2010) Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich’s ataxia patients and in a mouse model. PLoS One 5(1):e8825. CrossRefPubMedPubMedCentralGoogle Scholar
  55. Raybuck JD, McCleery EJ, Cunningham CL, Wood MA, Lattal KM (2013) The histone deacetylase inhibitor sodium butyrate modulates acquisition and extinction of cocaine-induced conditioned place preference. Pharmacol Biochem Behav 106:109–116. CrossRefPubMedPubMedCentralGoogle Scholar
  56. Richardson NR, Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66(1):1–11. CrossRefGoogle Scholar
  57. Rogge GA, Wood MA (2013) The role of histone acetylation in cocaine-induced neural plasticity and behavior. Neuropsychopharmacology, 38(1):94.Google Scholar
  58. Rogge GA, Singh H, Dang R, Wood MA (2013) HDAC3 is a negative regulator of cocaine-context-associated memory formation. J Neurosci 33(15):6623–6632. CrossRefPubMedPubMedCentralGoogle Scholar
  59. Romieu P, Host L, Gobaille S, Sandner G, Aunis D, Zwiller J (2008) Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci 28(38):9342–9348. CrossRefPubMedGoogle Scholar
  60. Romieu P, Deschatrettes E, Host L, Gobaille S, Sandner G, Zwiller J (2011) The inhibition of histone deacetylases reduces the reinstatement of cocaine-seeking behavior in rats. Curr Neuropharmacol 9(1):21–25. CrossRefPubMedPubMedCentralGoogle Scholar
  61. Rosen HJ, Pace-Savitsky K, Perry RJ, Kramer JH, Miller BL, Levenson RW (2004) Recognition of emotion in the frontal and temporal variants of frontotemporal dementia. Dement Geriatr Cogn Disord 17(4):277–281. CrossRefPubMedGoogle Scholar
  62. Rosenberg T, Gal-Ben-Ari S, Dieterich DC, Kreutz MR, Ziv NE, Gundelfinger ED, Rosenblum K (2014) The roles of protein expression in synaptic plasticity and memory consolidation. Front Mol Neurosci 7:1–14. CrossRefGoogle Scholar
  63. Sakharkar AJ, Zhang H, Tang L, Shi G, Pandey SC (2012) Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. Alcohol Clin Exp Res 36(1):61–71. CrossRefPubMedGoogle Scholar
  64. Sarkar S, Abujamra AL, Loew JE, Forman LW, Perrine SP, Faller DV (2011) Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res 31(9):2723–2732 Retrieved from PubMedGoogle Scholar
  65. Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007) Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62(1):55–64CrossRefGoogle Scholar
  66. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168:3–20. CrossRefGoogle Scholar
  67. Simon-O’Brien E, Alaux-Cantin S, Warnault V, Buttolo R, Naassila M, Vilpoux C (2015) The histone deacetylase inhibitor sodium butyrate decreases excessive ethanol intake in dependent animals. Addict Biol 20(4):676–689. CrossRefPubMedGoogle Scholar
  68. Singewald N, Schmuckermair C, Whittle N, Holmes A, Ressler KJ (2015) Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther 149:150–190CrossRefGoogle Scholar
  69. Stafford JM, Raybuck JD, Ryabinin AE, Lattal KM (2012) Increasing histone acetylation in the hippocampus-infralimbic network enhances fear extinction. Biol Psychiatry 72(1):25–33. CrossRefPubMedPubMedCentralGoogle Scholar
  70. Tran L, Schulkin J, Ligon CO, Greenwood-Van Meerveld B (2014) Epigenetic modulation of chronic anxiety and pain by histone deacetylation. Mol Psychiatry 20:1–13. CrossRefGoogle Scholar
  71. Vecsey CG, Hawk JD, Lattal KM, Stein JM, Fabian SA, Attner MA, Cabrera SM, McDonough CB, Brindle PK, Abel T, Wood MA (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 27(23):6128–6140. CrossRefPubMedPubMedCentralGoogle Scholar
  72. Venniro M, Caprioli D, Shaham Y (2016) Animal models of drug relapse and craving: from drug priming-induced reinstatement to incubation of craving after voluntary abstinence. Prog Brain Res 224:25–52. CrossRefPubMedGoogle Scholar
  73. Wang Y, Lai J, Cui H, Zhu Y, Zhao B, Wang W, Wei S (2015) Inhibition of histone deacetylase in the basolateral amygdala facilitates morphine context-associated memory formation in rats. J Mol Neurosci 55(1):269–278. CrossRefPubMedGoogle Scholar
  74. Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP et al (2001) Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci 937:1–26. CrossRefPubMedGoogle Scholar
  75. Whittle N, Singewald N (2014) HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand? Biochem Soc Trans 42:569–581CrossRefGoogle Scholar
  76. Whittle N, Schmuckermair C, Gunduz Cinar O, Hauschild M, Ferraguti F, Holmes A, Singewald N (2013) Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model. Neuropharmacology 64:414–426. CrossRefPubMedPubMedCentralGoogle Scholar
  77. Whittle N, Maurer V, Murphy C, Rainer J, Bindreither D, Hauschild M et al (2016) Enhancing dopaminergic signaling and histone acetylation promotes long-term rescue of deficient fear extinction. Transl Psychiatry 6(12):e974CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Leah N. Hitchcock
    • 1
  • Jonathan D. Raybuck
    • 1
  • Marcelo A. Wood
    • 2
  • K. Matthew Lattal
    • 1
    Email author
  1. 1.Department of Behavioral NeuroscienceOregon Health & Science UniversityPortlandUSA
  2. 2.Department of Neurobiology and BehaviorUniversity of California, IrvineIrvineUSA

Personalised recommendations